Pulse Methylprednisolone Therapy in Idiopathic Thrombocytopenic Purpurae
نویسندگان
چکیده
منابع مشابه
Bolus methylprednisolone therapy in adult idiopathic thrombocytopenic purpura.
Eleven patients with adult idiopathic thrombocytopenic purpura (ITP) were treated with bolus methylprednisolone at doses of 1 g/day for 3 days. In nine of eleven patients the platelet count rose to more than 100 X 10(9)/l during 2-9 days. In two other patients, it rose to 81 X 10(9)/l and 43 X 10(9)/l. In six of eleven patients splenectomy was carried out without any platelet transfusion when t...
متن کامل'Pulse' methylprednisolone and cyclophosphamide therapy in idiopathic rapidly progressive glomerulonephritis.
The clinical report of a 31-year-old man who developed acute renal failure due to idiopathic rapidly progressive glomerulonephritis is presented. Intravenous pulse methylprednisolone therapy in combination with cyclophosphamide resulted in marked improvement in renal function. The literature dealing with pulse therapy is reviewed.
متن کاملIntravenous pulse methylprednisolone in chronic idiopathic thrombocytopenia.
Two children with chronic idiopathic thrombocytopenic purpura unresponsive to either standard corticosteroid treatment or high dose intravenous gammaglobulin, or both, were treated with intravenous methylprednisolone (15 mg/kg/day) given in pulses over three consecutive days. Both children showed a positive response and are still in remission after three months.
متن کاملHigh-dose methylprednisolone for chronic idiopathic thrombocytopenic purpura.
Prof Şinasi Özsoylu, MD, Department of Pediatrics, Hematology Unit, Faculty of Medicine, Hacettepe University, Ankara 06100 (Turkey) I have read with interest the article by Mazzucconi et al. [1] entitled ‘Danazol Therapy in Refractory Chronic Immune Thrombocytopenic Purpura’ in the recent issue of the journal. I would like to bring to the authors’ attention that marked improvement of platelet ...
متن کاملPulse cyclophosphamide to treat idiopathic thrombocytopenic purpura.
In a recent Blood report,’ authors Reiner, Gernsheimer, and Slichter have concluded that pulse intravenous cyclophosphamide therapy should be strongly considered in idiopathic thrombocytopenic purpura (ITP) patients deemed “refractory to standard therapy.” In view of deficiencies in several aspects of this study, namely, patient selection, treatment goals, and data interpretation, we believe th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Haematologica
سال: 1983
ISSN: 0001-5792,1421-9662
DOI: 10.1159/000206772